Comments
Loading...
Bio View Analyst Ratings and Price Targets | OTC:BIVWF | Benzinga
Bio View Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Bio View Corp from these most-recent analyst ratings.
Analyst Ratings for Bio View
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Bio View (BIVWF) stock?
There is no price target for Bio View
What is the most recent analyst rating for Bio View (BIVWF)?
There is no analyst for Bio View
When was the last upgrade for Bio View (BIVWF)?
There is no last upgrade for Bio View
When was the last downgrade for Bio View (BIVWF)?
There is no last downgrade for Bio View.
When is the next analyst rating going to be posted or updated for Bio View (BIVWF)?
There is no next analyst rating for Bio View.
Is the Analyst Rating Bio View (BIVWF) correct?
There is no next analyst rating for Bio View.
Browse analyst ratings and price targets on all stocks.
